Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-07-2012 | Original Article

Tuberculous lymphadenitis: FDG PET and CT findings in responsive and nonresponsive disease

Authors: Mike Sathekge, Alex Maes, Yves D’Asseler, Mariza Vorster, Harlem Gongxeka, Christophe Van de Wiele

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 7/2012

Abstract

Purpose

No data is available on the different FDG PET and CT findings in the lymph nodes (LN) of patients with HIV and tuberculosis (TB) who respond compared with those who do not respond to anti-TB treatment by 4 months after initiation of TB treatment. These findings were the focus of our study.

Methods

PET/CT scans performed at 4 months after initiation of TB treatment in 20 consecutive HIV patients were analysed. SUVmax values were obtained for all regions of LN involvement. The diameter of the LNs was measured and the CT enhancement (LNs showing peripheral rim enhancement with central low attenuation, PRECLO, in comparison with homogeneously involved LNs) and the calcification patterns of involved LNs assessed. The relationship between the PET and CT findings and the clinical outcome, response or nonresponse, was evaluated.

Results

FDG PET identified 91 sites of LN involvement, 20 of which were not identified by CT. SUVmax values were significantly higher in nonresponders (8 patients, SUVmax 11.2 ± 4.0, mean ± SD) when compared to responders (12 patients, SUVmax 2.6 ± 2.3; p = 0.0001). In ROC analysis (AUC 0.952) a cut-off value of 4.5 for SUVmax yielded a sensitivity and specificity of 95 % and 85 % for discriminating nonresponding from responding LNs. LNs were significantly larger in nonresponders (1.9 ± 0.4 cm) than in responders (1.4 ± 0.4 cm; p = 0.0001); the AUC in the ROC analysis was 0.76. PRECLO LNs were significantly larger (2.2 ± 0.3 cm) than homogeneous involved LN basins (1.5 ± 0.4 cm) and LN basins with calcification (1.4 ± 0.5 cm; p = 0.001). Using the presence of at least one LN basin with PRECLO as a criterion for nonresponse, responders could be separated from nonresponders with a sensitivity of 88 % and a specificity of 66 %.

Conclusion

LNs responding to TB treatment could be differentiated from nonresponding LNs with a sensitivity and specificity of 95 % and 85 % using a SUVmax cut-off value of 4.5 and a sensitivity and specificity of 88 % and 66 % using the presence of at least one LN basin with PRECLO.

Arciniegas W, Orjuela D. Extrapulmonary tuberculosis: a review of 102 cases in Pereira, Colombia. Biomedica. 2006;26:71–80.PubMed

Golden M, Vikram H. Extrapulmonary tuberculosis: an overview. Am Fam Physician. 2005;72:1761–8.PubMed

Sharma S, Mohan A. Extrapulmonary tuberculosis. Indian J Med Res. 2004;120:316–53.PubMed

De Backer A, Mortele K, Deeren D, Vanschoubroeck J, De Keulenaer B. Abdominal tuberculous lymphadenopathy: MRI features. Eur Radiol. 2005;15:2104–9.PubMedCrossRef

Pombo F, Rodriguez E, Mato J, Perez-Fontan J, Rivera E, Valvuena L. Patterns of contrast enhancement of tuberculous lymph nodes demonstrated by computed tomography. Clin Radiol. 1992;46:13–7.PubMedCrossRef

Akhan O, Pringot J. Imaging of abdominal tuberculosis. Eur Radiol. 2002;12:312–23.PubMedCrossRef

Golden M, Holenarasipur V. Extrapulmonary tuberculosis: an overview. Am Fam Physician. 2005;72:1761–8.PubMed

Andrea J, Caceres J, Pallisa E, Martinez-Rodriguez M. Radiological manifestations of pulmonary tuberculosis. Eur J Radiol. 2004;51:139–49.CrossRef

Itoh H, Shim Y, Lee J, Ahn J, Han M, Noma S. Pulmonary tuberculosis: CT findings – early active disease and sequential changes with antituberculous therapy. Radiology. 1993;186:653–60.PubMed

10.

Sathekge M, Maes A, Kgomo M, Stoltz A, Pottel H, Van de Wiele C. Impact of FDG PET imaging on the management of tuberculosis treatment: a pilot study. Nuklearmedizin. 2010;49:35–40.PubMedCrossRef

11.

Matsui T, Nakata N, Nagai A, Takahashi M, Momose T, Ohtomo K, Koyasu S. Inflammatory cytokines and hypoxia contribute to 18F-FDG uptake by cells involved in pannus formation in rheumatoid arthritis. J Nucl Med. 2009;50:920–6.PubMedCrossRef

12.

Alavi A, Gupta J, Alberini M, Hickeson L, Adam E, Bhargava P, Zhuang H. Positron emission tomography in non-malignant thoracic disorders. Semin Nucl Med. 2002;32:293–321.PubMedCrossRef

13.

Paik J, Lee K, Choe S, Choi Y, Kim B. Augmented 18F-FDG uptake in activated monocytes occurs during the priming process and involves tyrosine kinases and protein-kinase C. J Nucl Med. 2004;45:124–8.PubMed

14.

Davis S, Nuermberger E, Um P, Vidal C, Jedynak B, Pomper M, Bishai W, Jain S. Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment. Antimicrob Agents Chemother. 2009;11:4879–84.CrossRef

15.

American Thoracic Society; CDC; Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep. 2003;52(RR-11):1–77.

16.

Schluger N. Keystone Symposia on Tuberculosis: from lab research to field trials (C6), abstract 041. Vancouver, British Columbia, Canada, 20–25 March 2007.

17.

Van Deun A, Martin A, Palomino JC. Diagnosis of drug-resistant tuberculosis: reliability and rapidity of detection. Int J Tuberc Lung Dis. 2010;14:131–40.PubMed

18.

Ahmad S, Mokaddas E. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis. Respir Med. 2009;103:1777–90.PubMedCrossRef

19.

Long R. Smear-negative pulmonary tuberculosis in industrialized countries. Chest 2001;120:330–4.PubMedCrossRef

20.

Mendelson M. Diagnosing tuberculosis in HIV-infected patients: challenges and future prospects. Br Med Bull. 2007;81–82:149–65.PubMedCrossRef

21.

Sathekge M, Maes A, Kgomo M, Pottel H, Stolz A, Van de Wiele C. FDG uptake in lymph nodes of HIV+ and tuberculosis patients: implications for cancer staging. Q J Nucl Med. 2010;6:698–703.

22.

Moon WK, Im JG, Yeon KM, Han MC. Mediastinal tuberculous lymphadenitis: CT findings of active and inactive disease. AJR Am J Roentgenol. 1998;170:715–8.PubMed

23.

Je B, Kim M, Kim S, Park D, Kim T, Lee N. Detailed nodal features of cervical tuberculous lymphadenitis on serial neck computed tomography before and after chemotherapy. J Comput Assist Tomogr. 2005;29:889–94.PubMedCrossRef

24.

Prasoon D. Acid-fast bacilli in fine needle aspiration smears from tuberculous lymph nodes. Acta Cytol. 2000;44:297–300.PubMedCrossRef

Title: Tuberculous lymphadenitis: FDG PET and CT findings in responsive and nonresponsive disease
Authors: Mike Sathekge
Alex Maes
Yves D’Asseler
Mariza Vorster
Harlem Gongxeka
Christophe Van de Wiele
Publication date: 01-07-2012
Publisher: Springer-Verlag
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 7/2012
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-012-2115-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Tuberculous lymphadenitis: FDG PET and CT findings in responsive and nonresponsive disease

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 7/2012

Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis

Even in times of crisis the distribution of knowledge is …

Cost-effectiveness analysis of FET PET-guided target selection for the diagnosis of gliomas

Pathogen identification by nuclear imaging – almost there?

Concomitant radio- and fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-99mTc-nanocolloid

Lymphoscintigraphy and SPECT/CT in multicentric and multifocal breast cancer: does each tumour have a separate drainage pattern?